|1.||Vergnolle, Nathalie: 2 articles (03/2003 - 03/2002)|
|2.||Hirono, Yasuo: 1 article (10/2015)|
|3.||Ueda, Yuki: 1 article (10/2015)|
|4.||Goi, Takanori: 1 article (10/2015)|
|5.||Yamaguchi, Akio: 1 article (10/2015)|
|6.||Fujimoto, Daisuke: 1 article (10/2015)|
|7.||Marsac, Bérengère: 1 article (07/2015)|
|8.||Bièche, Ivan: 1 article (07/2015)|
|9.||d'Audigier, Clément: 1 article (07/2015)|
|10.||Blandinières, Adeline: 1 article (07/2015)|
10/27/2015 - "The selective PAR1 agonist TFLLR-NH2 induces an increase in the fraction of side population cells which is enriched in CSCs, and promotes tumorigenesis, multi cancer drug resistance, cell morphological change, and cell invasion which are characteristics of CSCs. "
07/01/2015 - "Finally, the postnatal vasculogenic stem cell derived from infantile hemangioma tumor (HemSC) incubated with PAR-1-ap increased leukocyte recruitment in Matrigel(®) implant. "
06/01/2002 - "The PAR-1-activating peptide attenuates carrageenan-induced hyperalgesia in rats."
03/01/2002 - "Co-injection of PAR-1-AP with carrageenan significantly reduced carrageenan-induced mechanical and thermal hyperalgesia, while thrombin reduced carrageenan-induced mechanical but not thermal hyperalgesia. "
12/01/2005 - "Cultured C6 rat glioma cells were stimulated with human alpha-thrombin or PAR-1-AP. "
11/01/2001 - "Here we have studied the effect of THR and PAR-1-activating peptide (PAR1-AP), SFLLRN, on cytokine-induced expression of inducible nitric oxide (iNOS), a prominent marker of astroglial activation using the rat C6 glioma cells. "
12/01/2005 - "Both thrombin and its agonist, PAR-1-AP, significantly increased mRNA expression of pro-inflammatory cytokines in C6 glioma cells via PAR-1 activation."
|5.||Human Influenza (Influenza)
|4.||Messenger RNA (mRNA)
|5.||Nitric Oxide (Nitrogen Monoxide)
|7.||thrombin receptor peptide (42-47)